Galderma investigational Site

Warsaw 02-758

0 studies enrolling now · 5 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Prurigo Nodularis

Studies at this site

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Running, not enrolling
• Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris — Completed
• Dose-ranging Study of Nemolizumab in Atopic Dermatitis — Completed